Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127110061 | 12711006 | 1 | I | 20160830 | 20160902 | 20160902 | EXP | US-TEVA-689711USA | TEVA | 6.00 | DEC | F | Y | 0.00000 | 20160902 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127110061 | 12711006 | 1 | PS | TREANDA | BENDAMUSTINE HYDROCHLORIDE | 1 | Unknown | U | UNKNOWN | 22249 | |||||||||
| 127110061 | 12711006 | 2 | C | RITUXIMAB | RITUXIMAB | 1 | 0 | ||||||||||||
| 127110061 | 12711006 | 3 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127110061 | 12711006 | 1 | Chronic lymphocytic leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127110061 | 12711006 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127110061 | 12711006 | Asthma | |
| 127110061 | 12711006 | Chills | |
| 127110061 | 12711006 | Cough | |
| 127110061 | 12711006 | Nausea | |
| 127110061 | 12711006 | Pyrexia | |
| 127110061 | 12711006 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127110061 | 12711006 | 1 | 20160602 | 0 |